"Since 1986, Piedmont Transplant has been recognized as one of the nation’s most successful transplant programs, performing over 3,200 transplant surgeries for liver, pancreas, kidney and heart recipients."

During the past decade, Piedmont Transplant Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Piedmont Transplant Institute" are "Nonalcoholic Steatohepatitis" (2 trials), "Decompensated Cirrhosis" (1 trials), "Renal Transplantation" (1 trials) and "SARS-CoV-2" (1 trials). Many other conditions were trialed in "Piedmont Transplant Institute" in a lesser frequency.

Most popular intervention types in "Piedmont Transplant Institute" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo to match SEL 18 mg" (2 trials), "Placebo to match SEL 6 mg" (2 trials), "SEL" (2 trials), "Belatacept Less Intensive Regimen (LI)" (1 trials) and "Belatacept More Intensive Regimen (MI)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Piedmont Transplant Institute" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Piedmont Transplant Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Piedmont Transplant Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Piedmont Transplant Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".